BioMarin’s commercial chief Jeffrey Ajer hits the exit as new CEO looks to boost launch of Voxzogo, Roctavian badams Fri, 01/12/2024 – 10:13 More: BioMarin’s commercial chief Jeffrey Ajer hits the exit as new CEO looks to boost launch of
read moreFDA’s early review finds no evidence linking Novo, Lilly weight-loss drugs to suicidal thoughts kdunleavy Fri, 01/12/2024 – 09:36 More: FDA's early review finds no evidence linking Novo, Lilly weight-loss drugs to suicidal thoughts Source: fierce
read moreBoehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance esagonowsky Fri, 01/12/2024 – 09:09 More: Boehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance Source: fierce
read moreIf successful, the new test could see routine screening introduced in the NHS More: Cambridge researchers begin new trial for oesophageal cancer screening Source: News
read moreResearchers compared 20 years of antibiotic use on E. coli in the UK and Norway More: Study reveals antibiotic use is not the only driver of antibiotic resistance Source: News
read moreFierce Pharma Asia—Pfizer’s eye for China ADC deals; Astellas’ gastric cancer rejection zbecker Thu, 01/11/2024 – 20:52 More: Fierce Pharma Asia—Pfizer's eye for China ADC deals; Astellas' gastric cancer rejection Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals